BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21516413)

  • 1. Cell sensitivity assays: the ATP-based tumor chemosensitivity assay.
    Glaysher S; Cree IA
    Methods Mol Biol; 2011; 731():247-57. PubMed ID: 21516413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
    Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
    Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
    Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
    Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay.
    Qi CJ; Ning YL; Zhu YL; Min HY; Ye H; Qian KQ
    Arch Pharm Res; 2009 Dec; 32(12):1737-42. PubMed ID: 20162402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MTS vs. the ATP assay for in vitro chemosensitivity testing of primary glioma tumour culture.
    Dawson TP; Iyer RV; Lea RW; Roberts P; Harris E; Ashton K; Golash A; Davis CH
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):564-7. PubMed ID: 20524989
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
    Kurbacher CM; Cree IA
    Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
    Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
    Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT; Sevin BU
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
    Shi W; Gu M; Liang L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.
    Andreotti PE; Linder D; Hartmann DM; Cree IA; Pazzagli M; Bruckner HW
    J Biolumin Chemilumin; 1994; 9(6):373-8. PubMed ID: 7879653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
    Hunter EM; Sutherland LA; Cree IA; Dewar JA; Preece PE; Wood RA; Linder D; Andreotti PE
    Eur J Surg Oncol; 1993 Jun; 19(3):242-9. PubMed ID: 8314382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
    Nogaki M; Ichihashi H
    Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luminescence-based cell viability testing.
    Cree IA
    Methods Mol Biol; 1998; 102():169-77. PubMed ID: 9680619
    [No Abstract]   [Full Text] [Related]  

  • 15. ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects.
    Garewal HS; Ahmann FR; Schifman RB; Celniker A
    J Natl Cancer Inst; 1986 Nov; 77(5):1039-45. PubMed ID: 3464795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.
    Moon YW; Choi SH; Kim YT; Sohn JH; Chang J; Kim SK; Park MS; Chung KY; Lee HJ; Kim JH
    Cancer; 2007 May; 109(9):1829-35. PubMed ID: 17366594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5'-triphosphate.
    Rapaport E; Fishman RF; Gercel C
    Cancer Res; 1983 Sep; 43(9):4402-6. PubMed ID: 6871873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].
    Liu S; Qian X; Peng Z; Wang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):298-9, 312. PubMed ID: 12947719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of succinic dehydrogenase inhibition test with adenosine triphosphate inhibition assay for human solid tumors as in vitro chemosensitivity tests].
    Saeki T; Jinushi K; Kim R; Kirihara Y; Takagami S; Nishiyama M; Saeki K; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2025-30. PubMed ID: 2730092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The experiment and clinical evaluation of chemosensitivity test for esophageal and gastric cancer by ATP assay using endoscopic biopsy].
    Kawano K
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):232-40. PubMed ID: 1513305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.